PDK4-介导的代谢重编程是新血管与年龄相关的黄斑退行症的潜在治疗点
Juhee Kim1,2, Yujin Jeon1,2, Jinyoung Son3,4
1Department of Ophthalmology, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Republic of Korea.
Cell death & disease
|August 9, 2024
概括
向pyruvate脱酶激酶4 (PDK4) 可能治疗新血管与年龄相关的黄斑变性 (AMD). 在视网膜细胞中抑制PDK4可恢复线粒体功能并减少炎症,为AMD提供了新的治疗策略.
科学领域:
- 眼科医生 眼科 眼科
- 代谢研究的研究.
- 分子生物学分子生物学
背景情况:
- 与年龄相关的黄斑变性 (AMD) 通过与视网膜色素表皮 (RPE) 功能障碍相关的冠状腺新血管化 (CNV) 导致失明.
- 在RPE细胞中由炎症驱动的代谢重编程对于CNV发育至关重要.
- 线粒体的pyruvate脱酶激酶 (PDK) 在AMD病变发生中的作用以前未被探索.
研究的目的:
- 研究PDK异型在CNV中的作用.
- 评估PDK4抑制在新血管AMD中的治疗潜力.
主要方法:
- 使用激光诱导的CNV小鼠模型.
- 评估Pdk4基因切除和PDK抑制剂对CNV的影响.
- 在用炎症性细胞因子混合物 (ICM) 和PDK抑制剂或siRNA治疗的人类RPE细胞中检查了线粒体呼吸和炎症标志物.
- 在CNV小鼠模型中使用特定的PDK4抑制剂 (GM10395).
主要成果:
- 在CNV小鼠的RPE中,PDK4被上调;PDK4的切除减少了CNV.
- 在ICM治疗的人类RPE细胞中抑制PDK4恢复了线粒体呼吸,并降低了炎症性细胞因子分泌.
- 在RPE细胞中,GM10395治疗恢复了氧化酸化,并减少了炎症.
- 在小鼠模型中,GM10395显著减轻了CNV.
结论:
- 在AMD中,PDK4在RPE细胞的炎症代谢重编程中起着至关重要的作用.
- 特定的PDK4抑制是新血管AMD的一种有前途的治疗策略.
- 准PDK4可以防止线粒体功能障碍和导致AMD的炎症.
更多相关视频
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
10.1K
08:09Author Spotlight: Extended Oxygen Consumption Measurement in Retinal Pigment Epithelium Using Resipher
Published on: August 16, 2024
4.9K
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Electron Transport Chain: Complex I and II
12.5K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.5K
